Search

We dive into the archive of 2023 for insight and inspiration – this time with Carl June.

Why automated synthetic biology solutions can pave the way forward for both TCR-T and CAR-T research.

What role will CAR-Tregs play in the growing advanced therapy landscape?

Researchers seek a way to inactivate CAR-T cells in case of adverse effects.

We need more rapid sterility testing methods for frozen CAR-T drug products; here’s one potential approach

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

In what may have been one of the last advanced therapy meetings to go ahead for some time, delegates met in London in late February for CAR-TCR.

Advanced medicine companies are shifting their focus to off-the-shelf approaches, solid tumors, and combinations with immune checkpoint modulators.

Our latest news roundup reports on Vinay Prasad’s appointment, a personalized gene therapy for a baby with an ultra-rare condition, and more.

Our latest news roundup reports on research targeting solid tumors, a personalized CRISPR gene therapy for a young infant, a comedy show to raise mone